ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2019

Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy.

Eric D Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.